Last update June 23, 2022


Low Risk

Possibly safe. Probably compatible. Mild risk possible. Follow up recommended. Read the Comment.

Typical, first-generation antipsychotic. Prochlorperazine is a phenothiazine derivative with general properties similar to those of chlorpromazine. It is used in the treatment of schizophrenia, bipolar disorder, and severe anxiety. Oral, intramuscular or subcutaneous administration three or four times a day.

Since the last update we have not found published data on its excretion in breastmilk.

Its pharmacokinetic data (very wide volume of distribution and high percentage of protein binding) make it highly unlikely that significant quantities will pass into breast milk.

Its very low oral bioavailability makes it difficult for it to pass to the infant plasma from ingested breast milk, except in premature infants and in the immediate neonatal period in which there may be greater intestinal permeability.

Until more published data is known about this drug in relation to breastfeeding, known safer alternatives are preferable (Parikh 2014, Klinger 2013, WHO 2002), especially during the neonatal period and in the event of prematurity.

During breastfeeding, depot forms should be avoided because their long half-life can facilitate greater excretion in breast milk.

See below the information of this related product:


Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.

Jose Maria Paricio, Founder & President of APILAM/e-Lactancia

Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.

Thank you for helping to protect and promote breastfeeding.

José María Paricio, founder of e-lactancia.

Other names

Флуфеназин is Fluphenazine in Cyrillic.

Is written in other languages:

Флуфеназин is also known as


Флуфеназин belongs to these groups or families:


Main tradenames from several countries containing Флуфеназин in its composition:


Variable Value Unit
Oral Bioavail. 2.7 %
Molecular weight 438 daltons
Protein Binding 99 %
VD 3 l/Kg
pKa 15.59 -
Tmax 2; depot: 8-10 hours
4.4 - 16.4; depot: 336 hours


  1. Parikh T, Goyal D, Scarff JR, Lippmann S. Antipsychotic drugs and safety concerns for breast-feeding infants. South Med J. 2014 Abstract
  2. Klinger G, Stahl B, Fusar-Poli P, Merlob P. Antipsychotic drugs and breastfeeding. Pediatr Endocrinol Rev. 2013 Mar-Apr;10(3):308-17. Review. Abstract
  3. WHO / UNICEF. BREASTFEEDING AND MATERNAL MEDICATION Recommendations for Drugs in the Eleventh WHO Model List of Essential Drugs. Department of Child and Adolescent Health and Development (WHO/UNICEF) 2002 Abstract Full text (link to original source) Full text (in our servers)

Total visits


Help us improve this entry

How to cite this entry

Do you need more information or did not found what you were looking for?

   Write us at

e-lactancia is a resource recommended by El Parto Es Nuestro of Spain

Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM